LEADER 01598nam  2200397   450 
001 9910705120103321
005 20140311154230.0
035   $a(CKB)5470000002448159
035   $a(OCoLC)872279639
035   $a(EXLCZ)995470000002448159
100   $a20140311d2013      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aMedicaid prescription drugs $eCMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs : report to congressional requesters
205   $aRevised.
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2013.
215   $a1 online resource (iii, 40 pages) $cillustrations
300   $aTitle from title screen (viewed Feb. 13, 2014).
300   $a"December 2013."
300   $a"This report was revised on February 6, 2014 to correct the omission of reprinting written comments from the Department of Health and Human Services (HHS) on a draft report. A copy of the HHS's written comments was inserted in appendix V."
300   $a"GAO-14-68."
320   $aIncludes bibliographical references.
517   $aMedicaid prescription drugs 
606   $aMedicaid$xClaims administration
606   $aPrescription pricing$zUnited States
615  0$aMedicaid$xClaims administration.
615  0$aPrescription pricing
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910705120103321
996   $aMedicaid prescription drugs$93200996
997   $aUNINA